initiated coverage on shares of Lipocine ( – in a report issued on Wednesday. The firm issued a hold rating on the specialty pharmaceutical company's stock.
Mitch Edgeman is a journalist who covers a wide range of financial and investment topics. His articles focus on providing insights and analysis on various stocks, ETFs, and investment strategies. Mitch aims to provide readers with valuable information to make informed decisions in the world of finance.